Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (26503)	11/16/1998 9:03:00 AM
From: Alper H.YUKSEL	Read Replies (1) \| Respond to of 32384

Normally, the approval expectation should already be priced in LGND's current price. Do you expect any reaction to the news ? (That's too many questions for one morning, I know :)

To: Henry Niman who wrote (26503)	11/16/1998 10:54:00 AM
From: aknahow	Read Replies (2) \| Respond to of 32384

Henry, I was shocked to learn LGND was not featured at the FDA meeting. It is sharing the meeting with another company! I also learned, this morning that the answer generally given to the question, "Is there such a thing as a dumb question?", is wrong. Or perhaps, it is not wrong and indeed the U.S. government holds all its meetings on P.S.T. The bureaucrats would never be late, well almost never. To avoid excessively bullish or bearish post on LGND, it is also perhaps possible that the NASD has halted trading indefinitely, and not just for the morning. Having asked more than my own share of questions which also disprove the rule, about dumb questions, I hope no one takes more offense than they normally do on this board.<g> BTW, as a prudent company LGND might ask for a halt to allow for a smoother price adjustment should they not receive approval.